Gaurav Sharma

Chief Development Officer

As the Chief Development Officer, Gaurav is responsible for leading our development operations group (DevOps), consisting of strategic feasibility, study start up, project and clinical management, clinical monitoring, clinical development, and site management services including TMF group. He brings a rich background from both the biopharmaceutical and CRO perspective, as his previous experience includes leading Clinical Operations at Deciphera Pharmaceuticals, where he was operational asset lead for Rebastinib and ULK Inhibitor, as well as serving as SVP and Therapeutic Area Leader of Oncology & Hematology at Worldwide Clinical Trials where he focused on advanced therapies like cell and gene therapy. In addition, he held roles of progressive responsibility in project management starting at ICON Plc and then at Premier Research, where he served as SVP and Head of Global Project Management.

Gaurav holds a Master’s degree in Pharmacology from JSS College of Pharmacy.

Leading a new way

The latest from Caidya

Explore our news and updates as we liberate the clinical research process.

2024 ASCO Annual Meeting

1st June 2024 to 3rd June 2024
Chicago, IL

Pharmaceutical Contract Management Group (PCMG)

5th June 2024 to 6th June 2024
Den Haag, The Netherlands


Caidya Expands Global Presence with the Establishment of Caidya Canada Limited and New Office in Toronto

Morrisville, NC, USA, April 1, 2024 - Caidya, a leading...